Nitric Oxide and Cyclic GMP Signal Transduction in BrainNeurochemistry international. 2004, Vol 45, Num 6, issn 0197-0186, 178 p.Conference Proceedings

[Hyperammonemia and hepatic encephalopathy]FELIPO, Vicente.Metabolic brain disease. 2005, Vol 20, Num 4, issn 0885-7490, 189 p.Conference Proceedings

Modulation of soluble guanylate cyclase activity by phosphorylationMURTHY, Karnam S.Neurochemistry international. 2004, Vol 45, Num 6, pp 845-851, issn 0197-0186, 7 p.Conference Paper

Cyclic GMP transportersSAGER, Georg.Neurochemistry international. 2004, Vol 45, Num 6, pp 865-873, issn 0197-0186, 9 p.Conference Paper

cGMP: a second messenger for acetylcholine in the brain?DE VENTE, Jan.Neurochemistry international. 2004, Vol 45, Num 6, pp 799-812, issn 0197-0186, 14 p.Conference Paper

Effect of hypercholesterolemia and of oxidative stress on the nitric oxide-cGMP pathwayFRANCOIS, Michèle; KOJDA, Georg.Neurochemistry international. 2004, Vol 45, Num 6, pp 955-961, issn 0197-0186, 7 p.Conference Paper

Role of nitric oxide in the regulation of neuronal proliferation, survival and differentiationCONTESTABILE, Antonio; CIANI, Elisabetta.Neurochemistry international. 2004, Vol 45, Num 6, pp 903-914, issn 0197-0186, 12 p.Conference Paper

Neurophysiological investigation of hepatic encephalopathyAMODIO, Piero; GATTA, Angelo.Metabolic brain disease. 2005, Vol 20, Num 4, pp 369-379, issn 0885-7490, 11 p.Conference Paper

Endogenous neuroprotectants in ammonia toxicity in the central nervous system : Facts and hypothesesALBRECHT, Jan; WEGRZYNOWICZ, Michat.Metabolic brain disease. 2005, Vol 20, Num 4, pp 253-263, issn 0885-7490, 11 p.Conference Paper

Limited capacity for ammonia removal by brain in chronic liver failure : Potential role of nitric oxideROSE, Christopher; FELIPO, Vicente.Metabolic brain disease. 2005, Vol 20, Num 4, pp 275-283, issn 0885-7490, 9 p.Conference Paper

Role of phosphate-activated glutaminase in the pathogenesis of hepatic encephalopathyROMERO-GOMEZ, Manuel.Metabolic brain disease. 2005, Vol 20, Num 4, pp 319-325, issn 0885-7490, 7 p.Conference Paper

Elements of the nitric oxide/cGMP pathway expressed in cerebellar granule cells : biochemical and functional characterisationJURADO, Sandra; SANCHEZ-PRIETO, José; TORRES, Magdalena et al.Neurochemistry international. 2004, Vol 45, Num 6, pp 833-843, issn 0197-0186, 11 p.Conference Paper

Acute liver failure : A critical appraisal of available animal modelsBELANGER, Mireille; BUTTERWORTH, Roger F.Metabolic brain disease. 2005, Vol 20, Num 4, pp 409-423, issn 0885-7490, 15 p.Conference Paper

Chronic systemic endotoxin exposure : An animal model in experimental hepatic encephalopathyLINDROS, Kai O; JÄRVELÄINEN, Harri A.Metabolic brain disease. 2005, Vol 20, Num 4, pp 393-398, issn 0885-7490, 6 p.Conference Paper

Wilson diseaseKITZBERGER, Reinhard; MADL, Christian; FERENCI, Peter et al.Metabolic brain disease. 2005, Vol 20, Num 4, pp 295-302, issn 0885-7490, 8 p.Conference Paper

Role of endogenous benzodiazepine ligands and their GABA-A-associated receptors in hepatic encephalopathyAHBOUCHA, Samir; BUTTERWORTH, Roger F.Metabolic brain disease. 2005, Vol 20, Num 4, pp 425-437, issn 0885-7490, 13 p.Conference Paper

Modulation of synaptic function by cGMP and cGMP-gated cation channelsBARNSTABLE, Colin J; WEI, Ji-Ye; HAN, Ming-Hu et al.Neurochemistry international. 2004, Vol 45, Num 6, pp 875-884, issn 0197-0186, 10 p.Conference Paper

Modulation of Ca_v1 and Ca_v2.2 channels induced by nitric oxide via cGMP-dependent protein kinaseGRASSI, Claudio; D'ASCENZO, Marcello; AZZENA, Gian Battista et al.Neurochemistry international. 2004, Vol 45, Num 6, pp 885-893, issn 0197-0186, 9 p.Conference Paper

Specific localized expression of cGMP PDEs in Purkinje neurons and macrophagesBENDER, Andrew T; BEAVO, Joseph A.Neurochemistry international. 2004, Vol 45, Num 6, pp 853-857, issn 0197-0186, 5 p.Conference Paper

The NOS/sGC pathway in the rat central nervous system: a microdialysis overviewPEPICELLI, Olimpia; RAITERI, Maurizio; FEDELE, Ernesto et al.Neurochemistry international. 2004, Vol 45, Num 6, pp 787-797, issn 0197-0186, 11 p.Conference Paper

Protein tyrosine nitration in hyperammonemia and hepatic encephalopathyHÄUSSINGER, Dieter; GÖRG, Boris; REINEHR, Roland et al.Metabolic brain disease. 2005, Vol 20, Num 4, pp 285-294, issn 0885-7490, 10 p.Conference Paper

Molecular mechanisms of the alterations in NMDA receptor-dependent long-term potentiation in hyperammonemiaMONFORT, Pilar; MUNOZ, Maria-Dolores; FELIPO, Vicente et al.Metabolic brain disease. 2005, Vol 20, Num 4, pp 265-274, issn 0885-7490, 10 p.Conference Paper

Mechanisms of ammonia-induced astrocyte swellingNORENBERG, M. D; RAMA RAO, K. V; JAYAKUMAR, A. R et al.Metabolic brain disease. 2005, Vol 20, Num 4, pp 303-318, issn 0885-7490, 16 p.Conference Paper

Which are the right cells to be used in a bioartificial liver?CHAMULEAU, Robert A. F. M; DEURHOLT, Tanja; HOEKSTRA, Ruurdtje et al.Metabolic brain disease. 2005, Vol 20, Num 4, pp 327-335, issn 0885-7490, 9 p.Conference Paper

Signaling in the mammalian circadian clock: the NO/cGMP pathwayGOLOMBEK, Diego A; AGOSTINO, Patricia V; PIANO, Santiago A et al.Neurochemistry international. 2004, Vol 45, Num 6, pp 929-936, issn 0197-0186, 8 p.Conference Paper